Additive manufacturing, commonly known as 3D printing technology, has become a prominent topic of research globally in recent years and is playing an increasingly important role in various industries. Particularly within the healthcare sector, the use of 3D printing technology is gaining prominence, with a special focus on the manufacturing and application of dental implants. As research in this field progresses, the preparation methods, material selection, and technological innovations for dental implants are evolving, promising a future where the manufacturing process of dental implants becomes even more refined and efficient. Through thorough research in materials science, it is possible to develop dental implant materials that have better biocompatibility with the human body and improved mechanical properties. Additionally, advancements in surface modification technology can further enhance the strength and stability of the bond between dental implants and bone tissue. These advancements not only expand treatment options for patients but also greatly improve the long-term success rate of dental implants. In the field of dental implants, the success of the implant depends on the interactions between the materials used, the cells involved, and the bone tissue. Therefore, there is an urgent need to explore the molecular mechanisms of such interactions in depth. In this study, we provide a comprehensive review of the application of 3D printing technology in the fabrication of dental implants. This includes an examination of the process methods, surface coating technology, and a comparison of the shapes and structures of different dental implants, along with their advantages and disadvantages. Furthermore, this paper analyzes the intrinsic mechanisms of successful dental implant placement in clinical practice, and it highlights the latest progress in the clinical application of 3D-printed dental implants. Undeniably, the use of 3D-printed dental implants not only offers patients more precise and personalized treatment plans but also brings revolutionary changes to the development of the medical industry.
15 June 2024 in Journal of Cranio-Maxillofacial Surgery
Objective: Polyetheretherketone (PEEK) is widely used as an orthopedic implant material owing to its good biocompatibility and mechanical strength; however, PEEK implants are biologically inert, resulting in suboptimal cellular responses after implantation. The aim of this study was to enhance the biological activity of PEEK through sulfonation treatment. Methods: In this study, distal phalangeal implants of PEEK were customized by fused deposition modeling (FDM) printing technology and soaked in concentrated sulfuric acid at different times to obtain sulfonated PEEK (SPEEK). The groups were divided into five groups according to the sulfonation time as follows: 0 min (control group), 1 min (group SPEEK1), 2 min (group SPEEK2), 4 min (group SPEEK4), and 8 min (group SPEEK8). Then the physicochemical characteristics of implants were determined by SEM, XRD, EDS, etc. The implants were co-cultured with stem cells from human exfoliated deciduous teeth (SHED), and then the cell proliferation, adhesion, alkaline phosphatase (ALP) activity, and alizarin red staining were performed to detect the biological activity, biocompatibility, and osteogenic activity of the SPEEK implants. Results: The sulfonation time range of 1 to 8 min could promote the formation of micropores on the surface of PEEK implants, while slightly affecting the composition and compression performance of the implants. Compared with the control group, the hydrophilicity of PEEK materials was not improved after sulfonation treatment. Tests for adhesion and proliferation of SHED indicated that SPEEK2 showed superior biocompatibility. Furthermore, ALP activity and semi-quantitative analysis of Alizarin red staining showed that the osteogenic activity of SPEEK2 phalanges exhibited significantly stronger osteogenic activity than the other groups. Conclusions: The method presented here provides a promising approach to improve the surface bioactivity of PEEK implants prepared by FDM, providing a shred of primary evidence to support the application of SPEEK in orthopedics.
The treatment of critical-sized bone defects remains a substantial clinical challenge in orthopaedics. Electrical stimulation (ES), which mimics the endogenous bioelectric and piezoelectric properties of bone tissue, has emerged as a promising non-invasive modality to facilitate bone regeneration. This review elucidates the multifaceted mechanisms through which ES coordinately enhances osteogenesis, angiogenesis, and inflammation resolution, primarily via the regulation of key signalling pathways and modulation of the immune microenvironment at molecular and cellular levels. We also highlight recent advances in the integration of ES with electroactive biomaterials, enabling more targeted and efficacious therapeutic outcomes. Robust clinical evidence supports the ability of ES to significantly accelerate fracture healing, underscoring its translational relevance and potential for broad clinical adoption. By synthesizing these developments, this review aims to inform and inspire the design of next-generation bone regeneration strategies. ES offers a non-invasive or minimally invasive therapeutic modality that can significantly accelerate fracture healing and bone regeneration. This review synthesizes current mechanistic understanding and clinical evidence, highlighting ES as a potential alternative to secondary revision surgery for nonunion fractures. By integrating ES with electroactive biomaterials and emerging self-powered implantable devices, future strategies can be translated into personalized, intelligent bone repair systems, reducing patient morbidity and healthcare costs.
Glioblastoma (GBM) is the most common and aggressive primary brain tumor with a poor prognosis due to its immunosuppressive microenvironment. Reliable prognostic biomarkers are still lacking. This study aims to construct an immune-related gene signature to predict the prognosis of GBM patients and explore the molecular characteristics of different immune subtypes. The Cancer Genome Atlas (TCGA), the Chinese Glioma Genome Atlas (CGGA), and Gene Expression Omnibus Series (GSE) 108474 datasets were integrated to classify cold and hot tumor subtypes via single-sample gene set enrichment analysis (ssGSEA) and partitioning around medoids (PAM) clustering. Prognostic genes were identified via weighted gene co-expression network analysis (WGCNA) and screened with 101 machine learning (ML) algorithms. A risk-scoring model was developed, and gene expression was validated via single-cell transcriptomics and immunohistochemistry (IHC). Seven core genes were identified, with area under the curve (AUC) values of 0.75–0.88 for distinguishing cold/hot subtypes. The model exhibited stable predictive performance in external validation cohorts (AUC =0.55–0.69). The survival rate of the high-risk cold tumor cohort was significantly lower than that of the low-risk hot tumor cohort. Our study identifies key genes and molecular mechanisms underlying the immune microenvironment of GBM. The prognostic model developed lays a theoretical foundation for personalized immunotherapy and stratified treatments.